Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies.

Tuazon SA, Li A, Gooley T, Eunson TW, Maloney DG, Turtle CJ, Linenberger ML, Connelly-Smith LS.

Transfusion. 2019 Feb 6. doi: 10.1111/trf.15178. [Epub ahead of print]

PMID:
30729531
2.

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE.

Biol Blood Marrow Transplant. 2018 Dec 31. pii: S1083-8791(18)31698-7. doi: 10.1016/j.bbmt.2018.12.765. [Epub ahead of print]

PMID:
30605731
3.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL.

Biol Blood Marrow Transplant. 2018 Nov 10. pii: S1083-8791(18)30698-0. doi: 10.1016/j.bbmt.2018.11.004. [Epub ahead of print]

PMID:
30423480
4.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE.

Haematologica. 2018 Oct 31. pii: haematol.2018.200121. doi: 10.3324/haematol.2018.200121. [Epub ahead of print]

5.

Choosing Wisely for apheresis.

Connelly-Smith L, Tanhehco YC, Chhibber V, Delaney M, Eichbaum Q, Fernandez C, Joshi S, Schwartz J, Linenberger M.

J Clin Apher. 2018 Oct;33(5):576-579. doi: 10.1002/jca.21643.

PMID:
30325055
6.

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

Samuelson Bannow BT, Salit RB, Storer BE, Stevens EA, Wu D, Yeung C, Fang M, Petersdorf EW, Linenberger ML, Woo J, Sorror ML, Doney K, Sandmaier BM, Deeg HJ, Scott BL.

Biol Blood Marrow Transplant. 2018 Feb;24(2):386-392. doi: 10.1016/j.bbmt.2017.09.016. Epub 2017 Sep 29.

7.

Transfusion practices for bone marrow harvests: a survey analysis from the AABB Bone Marrow Quality Improvement Initiative Working Group.

Spitzer TR, Sugrue MW, Gonzalez C, O'Donnell P, Confer D, Fuchs E, Pulsipher MA, Schwartz J, Linenberger M.

Bone Marrow Transplant. 2017 Aug;52(8):1199-1200. doi: 10.1038/bmt.2017.92. Epub 2017 May 22. No abstract available.

PMID:
28530670
8.

Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study.

Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA.

Biol Blood Marrow Transplant. 2017 Jan;23(1):165-171. doi: 10.1016/j.bbmt.2016.10.008. Epub 2016 Oct 14.

9.

Splenic infarction and G-CSF.

Al-Khinji A, Linenberger M.

Transfusion. 2015 Apr;55(4):708. doi: 10.1111/trf.12851. No abstract available.

PMID:
26840787
10.

Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee.

O'Leary MF, Dunbar NM, Kim HC, Draper NL, Linenberger M, Schwartz J, Miller Y, Murtaugh A, West FB, Fernando LP, Park YA.

J Clin Apher. 2016 Dec;31(6):529-534. doi: 10.1002/jca.21445. Epub 2016 Jan 13.

PMID:
26762291
11.

A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer.

Blau CA, Ramirez AB, Blau S, Pritchard CC, Dorschner MO, Schmechel SC, Martins TJ, Mahen EM, Burton KA, Komashko VM, Radenbaugh AJ, Dougherty K, Thomas A, Miller CP, Annis J, Fromm JR, Song C, Chang E, Howard K, Austin S, Schmidt RA, Linenberger ML, Becker PS, Senecal FM, Mecham BH, Lee SI, Madan A, Ronen R, Dutkowski J, Heimfeld S, Wood BL, Stilwell JL, Kaldjian EP, Haussler D, Zhu J.

J Natl Compr Canc Netw. 2016 Jan;14(1):8-17.

12.

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.

Schmitz-Abe K, Ciesielski SJ, Schmidt PJ, Campagna DR, Rahimov F, Schilke BA, Cuijpers M, Rieneck K, Lausen B, Linenberger ML, Sendamarai AK, Guo C, Hofmann I, Newburger PE, Matthews D, Shimamura A, Snijders PJ, Towne MC, Niemeyer CM, Watson HG, Dziegiel MH, Heeney MM, May A, Bottomley SS, Swinkels DW, Markianos K, Craig EA, Fleming MD.

Blood. 2015 Dec 17;126(25):2734-8. doi: 10.1182/blood-2015-09-659854. Epub 2015 Oct 21.

13.

Defining the quality of hematopoietic stem cell products: the devil is in the details.

Tanhehco YC, Schwartz J, Linenberger ML.

Transfusion. 2015 Oct;55(10):2300-3. doi: 10.1111/trf.13262. No abstract available.

PMID:
26459961
14.

A case of benign Pelger-Huët anomaly.

Roberts T, Linenberger M.

Blood. 2015 Jul 30;126(5):693. No abstract available.

15.

Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients.

Fang M, Becker PS, Linenberger M, Eaton KD, Appelbaum FR, Dreyer Z, Airewele G, Redell M, Lopez-Terrada D, Patel A, Rabin KR, Lu X.

Am J Clin Pathol. 2015 Aug;144(2):263-70. doi: 10.1309/AJCPW83OXPYKPEEN.

PMID:
26185311
16.

Atypical lymphocytes and eosinophilia in primary cytomegalovirus mononucleosis.

Roberts T, Linenberger M, Chen X.

Br J Haematol. 2015 Nov;171(4):441. doi: 10.1111/bjh.13590. Epub 2015 Jul 7. No abstract available.

PMID:
26153369
17.

NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology.

Karafin MS, Sachais BS, Connelly-Smith L, Field JJ, Linenberger ML, Padmanabhan A.

J Clin Apher. 2016 Feb;31(1):38-47. doi: 10.1002/jca.21400. Epub 2015 May 4.

PMID:
25940408
18.

Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy.

Phipps C, Linenberger M, Holmberg LA, Green D, Becker P, Connelly-Smith L, Klippel Z, Burwick N, Gopal A, Bensinger WI, Libby E.

Bone Marrow Transplant. 2015 May;50(5):663-7. doi: 10.1038/bmt.2015.13. Epub 2015 Mar 2.

PMID:
25730190
19.

Therapeutic apheresis for patients with cancer.

Connelly-Smith LS, Linenberger ML.

Cancer Control. 2015 Jan;22(1):60-78. Review.

PMID:
25504280
20.

Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger Survey.

Makar RS, Padmanabhan A, Kim HC, Anderson C, Sugrue MW, Linenberger M.

Transfus Med Rev. 2014 Oct;28(4):198-204. doi: 10.1016/j.tmrv.2014.08.002. Epub 2014 Aug 27. Review.

PMID:
25311468
21.

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C.

J Clin Oncol. 2014 Aug 1;32(22):2365-72. doi: 10.1200/JCO.2013.54.4577. Epub 2014 Jun 30.

22.

American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia.

Shaz BH, Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Szczepiorkowski ZM, Williams ME, Wu Y, Linenberger ML.

Clin Infect Dis. 2014 Jan;58(2):302-3. doi: 10.1093/cid/cit662. Epub 2013 Oct 2. No abstract available.

PMID:
24092801
23.

Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH.

J Clin Apher. 2013 Jul;28(3):145-284. doi: 10.1002/jca.21276.

PMID:
23868759
24.

Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.

Eisenberg S, Wickline M, Linenberger M, Gooley T, Holmberg L.

Oncol Nurs Forum. 2013 May 1;40(3):285-92. doi: 10.1188/13.ONF.285-292.

PMID:
23615140
25.

Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature.

Pagano MB, Hobbs W, Linenberger M, Delaney M.

J Clin Apher. 2012;27(6):336-41. doi: 10.1002/jca.21249. Epub 2012 Sep 21.

PMID:
22997063
26.

The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cells.

Gopal AK, Karami M, Mayor J, Macebeo M, Linenberger M, Bensinger WI, Holmberg L.

J Clin Apher. 2012;27(2):81-7. doi: 10.1002/jca.21206. Epub 2012 Feb 2.

27.

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.

Scott BL, Gooley TA, Sorror ML, Rezvani AR, Linenberger ML, Grim J, Sandmaier BM, Myerson D, Chauncey TR, Storb R, Buxhofer-Ausch V, Radich JP, Appelbaum FR, Deeg HJ.

Blood. 2012 Mar 15;119(11):2657-64. doi: 10.1182/blood-2011-08-372904. Epub 2012 Jan 10.

28.

Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.

Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger M.

Biol Blood Marrow Transplant. 2012 Feb;18(2):220-8. doi: 10.1016/j.bbmt.2011.06.003. Epub 2011 Jun 15.

29.

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH; Apheresis Applications Committee of the American Society for Apheresis.

J Clin Apher. 2010;25(3):83-177. doi: 10.1002/jca.20240.

PMID:
20568098
30.

Chasing clot: thrombophilic states and the interventionalist.

Valji K, Linenberger M.

J Vasc Interv Radiol. 2009 Nov;20(11):1403-16; quiz 1417. doi: 10.1016/j.jvir.2009.08.015. Review.

PMID:
19875057
31.

Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.

Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, Lee J, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB, Vedantham S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2008 Sep;6(8):716-53. No abstract available.

PMID:
18926086
32.

Acute myeloid leukemia in a healthy hematopoietic stem cell donor following past exposure to a short course of G-CSF.

Hsia CC, Linenberger M, Howson-Jan K, Mangel J, Chin-Yee IH, Collins S, Xenocostas A.

Bone Marrow Transplant. 2008 Sep;42(6):431-2. doi: 10.1038/bmt.2008.205. Epub 2008 Jul 21. Review. No abstract available.

PMID:
18641683
33.

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL; American Society for Apheresis; Apheresis Applications Committee of the American Society for Apheresis.

J Clin Apher. 2007 Jun;22(3):106-75.

PMID:
17394188
34.

Category IV indications for therapeutic apheresis: ASFA fourth special issue.

Shaz BH, Linenberger ML, Bandarenko N, Winters JL, Kim HC, Marques MB, Sarode R, Schwartz J, Weinstein R, Wirk A, Szczepiorkowski ZM.

J Clin Apher. 2007 Jun;22(3):176-80. Review.

PMID:
17377982
35.

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.

Kerbauy DM, Gooley TA, Sale GE, Flowers ME, Doney KC, Georges GE, Greene JE, Linenberger M, Petersdorf E, Sandmaier BM, Scott BL, Sorror M, Stirewalt DL, Stewart FM, Witherspoon RP, Storb R, Appelbaum FR, Deeg HJ.

Biol Blood Marrow Transplant. 2007 Mar;13(3):355-65.

36.

Catheter-related thrombosis: risks, diagnosis, and management.

Linenberger ML.

J Natl Compr Canc Netw. 2006 Oct;4(9):889-901. Review.

PMID:
17020667
37.

Venous thromboembolic disease. Clinical practice guidelines in oncology.

Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Oct;4(9):838-69. No abstract available.

PMID:
17020664
38.

Thromboembolic complications of malignancy. Part 2: management.

Linenberger ML, Wittkowsky AK.

Oncology (Williston Park). 2005 Jul;19(8):1077-84; discussion 1084, 1087-8. Review.

39.

Thromboembolic complications of malignancy. Part 1: Risks.

Linenberger ML, Wittkowsky AK.

Oncology (Williston Park). 2005 Jun;19(7):853-61. Review.

40.

Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.

Linenberger ML, Price TH.

J Intensive Care Med. 2005 Mar-Apr;20(2):88-103. Review.

PMID:
15855221
41.

Use of cellular and plasma apheresis in the critically ill patient: part 1: technical and physiological considerations.

Linenberger ML, Price TH.

J Intensive Care Med. 2005 Jan-Feb;20(1):18-27. Review.

PMID:
15665256
43.

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.

Walter RB, Raden BW, Thompson J, Flowers DA, Kiem HP, Bernstein ID, Linenberger ML.

Leukemia. 2004 Nov;18(11):1914-7. No abstract available.

PMID:
15385942
44.

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

Walter RB, Raden BW, Hong TC, Flowers DA, Bernstein ID, Linenberger ML.

Blood. 2003 Aug 15;102(4):1466-73. Epub 2003 Apr 10.

45.

Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.

Reiner AP, Frank MB, Schwartz SM, Linenberger ML, Longstreth WT, Teramura G, Rosendaal FR, Psaty BM, Siscovick DS.

Br J Haematol. 2002 Feb;116(2):376-82.

PMID:
11841441
46.

Antibody-directed therapies for hematological malignancies.

Linenberger ML, Maloney DG, Bernstein ID.

Trends Mol Med. 2002 Feb;8(2):69-76. Review.

PMID:
11815272
47.

Mylotarg: antibody-targeted chemotherapy comes of age.

Sievers EL, Linenberger M.

Curr Opin Oncol. 2001 Nov;13(6):522-7. Review.

PMID:
11673694
48.

Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.

Linenberger ML, Hong T, Flowers D, Sievers EL, Gooley TA, Bennett JM, Berger MS, Leopold LH, Appelbaum FR, Bernstein ID.

Blood. 2001 Aug 15;98(4):988-94.

49.

Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family.

Linenberger ML, Kindelan J, Bennett RL, Reiner AP, Côté HC.

Am J Hematol. 2000 Aug;64(4):242-50.

PMID:
10911375
50.

The effects of feline retroviruses on cytokine expression.

Linenberger ML, Deng T.

Vet Immunol Immunopathol. 1999 Dec 30;72(3-4):343-68.

PMID:
10628677

Supplemental Content

Loading ...
Support Center